Bayer CropScience Completes Acquisition of U.S. Biotech Firm for $365 Million
05:42 AM | November 3, 2009 | Deepti Ramesh
Bayer CropScience says it has completed the previously announced acquisition of Athenix (Research Triangle Park, NC), a privately held biotechnology company, for $365 million. Further cash payments...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.